Glox to develop precision antibiotics for cystic fibrosis
The funding is provided by LifeArc, a medical research charity.
Drug Development
J&J’s Spravato receives FDA label expansion for depression monotherapy
Junshi partners LEO Pharma for toripalimab distribution in Europe
KeyMed partners with US-based biotech Prolium in bispecific antibody deal
AstraZeneca secures first BTK approval in first-line mantle cell lymphoma
Feinstein Institutes gains NIH grant to explore ghrelin for GI-ARS
Lyndra and Thermo Fisher partner for oral therapies
Be Bio secures $92m for haemophilia B and hypophosphatasia treatments
